drugset / Trial / NCT05391048
An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition
RandomizedCrossoverOpen-labelOther
Summary
An open-label, randomized, single-dose, two-way crossover bioequivalence study to compare two strengths (10 mg and 20 mg) of IMP4297 capsules in healthy Chinese subjects under fed condition
Timeline
- Start
- 2022-06-06
- Primary completion
- 2022-07-21
- Completion
- 2022-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMP4297 | Unknown | 10 mg | Oral |
| Subject | IMP4297 | Unknown | 20 mg | Oral |